News & blog

Redx Plans Alderley Park Switch

Listed drug developer Redx Pharma has unveiled plans to relocate its head office from Liverpool to Alderley Park, with chief executive Neil Murray telling Insider that the Cheshire bioscience hub is a “truly world-class facility”.

The company has outlined plans to create a 74,000 sq ft drug development facility that brings together its three subsidiaries onto a single site.

It has reached an agreement with science park operator Manchester Science Partnerships that will see Alderley Park become the new home for Redx Oncology. The business develops anti-cancer drugs and is currently based within the Royal Liverpool Hospital’s Duncan Building, which is due to be demolished in 2017.

Redx already has two other subsidiaries, Redx Anti-Infectives and Redx Immunology, based at Alderley Park in 37,000 sq ft of laboratory and office space. Read More